Lpl Financial LLC Akebia Therapeutics, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 44,135 shares of AKBA stock, worth $79,001. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,135

Previous 58,032 23.95%

Holding current value

$79,001

Previous $59,000 1.69%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$0.94 - $1.55 $13,063 - $21,540	-13,897 Reduced 23.95%	44,135 $58,000
Q2 2024 Aug 07, 2024	BUY	$0.86 - $1.63 $34,560 - $65,504	40,187 Added 225.2%	58,032 $59,000
Q1 2024 May 10, 2024	BUY	$1.27 - $2.24 $22,663 - $39,972	17,845 New	17,845 $32,000
Q1 2023 May 10, 2023	BUY	$0.56 - $1.15 $16,013 - $32,885	28,596 New	28,596 $16,000
Q3 2020 Nov 09, 2020	SELL	$2.39 - $13.08 $84,352 - $461,645	-35,294 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$6.67 - $13.58 $6,609 - $13,457	-991 Reduced 2.73%	35,294 $479,000
Q1 2020 May 14, 2020	BUY	$4.1 - $10.24 $6,256 - $15,626	1,526 Added 4.39%	36,285 $275,000
Q4 2019 Feb 14, 2020	BUY	$3.16 - $6.73 $7,059 - $15,034	2,234 Added 6.87%	34,759 $220,000
Q3 2019 Nov 13, 2019	SELL	$3.55 - $5.4 $3,631 - $5,524	-1,023 Reduced 3.05%	32,525 $127,000
Q2 2019 Aug 09, 2019	SELL	$4.1 - $8.05 $1,803 - $3,542	-440 Reduced 1.29%	33,548 $162,000
Q1 2019 May 08, 2019	BUY	$5.41 - $8.73 $30,972 - $49,979	5,725 Added 20.26%	33,988 $278,000
Q4 2018 Feb 07, 2019	BUY	$5.39 - $9.15 $8,084 - $13,725	1,500 Added 5.6%	28,263 $156,000
Q3 2018 Nov 14, 2018	BUY	$7.44 - $10.65 $54,416 - $77,894	7,314 Added 37.61%	26,763 $236,000
Q2 2018 Aug 14, 2018	BUY	$9.15 - $11.34 $177,958 - $220,551	19,449 New	19,449 $194,000
Q1 2018 May 15, 2018	SELL	$9.53 - $15.68 $224,517 - $369,405	-23,559 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$14.24 - $19.59 $335,480 - $461,520	23,559	23,559 $350,000

Others Institutions Holding AKBA

# of Institutions

121

Shares Held

54.8M

Call Options Held

291K

Put Options Held

179K

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $329M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Akebia Therapeutics, Inc. Transaction History